stem-cell-congress-cardiology-2018-keynote

allied

academies

CARDIOLOGY AND CARDIOVASCULAR MEDICINE

STEM CELLS AND REGENERATIVE MEDICINE

International Conference on

J u n e 1 8 - 1 9 , 2 0 1 8 | O s a k a , J a p a n

Biomedical Research

Volume 29

Page 28

Note:

Joint Event on

t present there is no convincing evidence that existing “antiaging”

treatments can slow aging or increase longevity. However, a variety

of experiments in both animals and humans indicate that aging rates

and life expectancy can be altered. General strategies that appear

promising include interventions that reduce oxidative stress and cell

replacement therapies can deal with specific age-related pathologies.

Telomere length (TL) in blood cells is considered as a molecular marker

of ageing. Circulating cell-free DNA (cfDNA) and unconjugated bilirubin

(UCB) are dynamic blood constituents that need to be further explored.

As we age, and in certain diseased states our cellular ability to translate

a transcribedmRNAcode into a functional protein, is impaired. Although

the genesis of this clinical condition can be somewhat complex, it is

characterized by intra-cellular protein accumulation. This accumulation

not only decreases cellular function, but also impedes the translational

capacity of the cell. We believe the primary etiology of this is a decrease

in Chaperone Protein function inside the cell. In this paper we report

that cellular aging is marked by an increase in both circulating HSP70

and cfDNA, which are significantly correlated to each other.

Biography

Kampon Sriwatanakul is the president of Vita

Stem Co. Ltd., Bangkok and an internationally

recognized pioneer of stemcell therapy. He is cur-

rently engaged in research and development proj-

ects related to application of mesenchymal stem

cell in the anti-aging and regenerative medicine.

APPLICATIONS OF STEM CELL

TECHNOLOGY IN ANTI- AGING

MEDICINE

Kampon Sriwatanakul

Vita Stem Co. Ltd., Thailand

Kampon Sriwatanakul, Biomed Res 2018, Volume 29 | DOI: 10.4066/biomedicalresearch-C2-004